Oral antimicrobial options for the treatment of skin and soft-tissue infections caused by meticillin-resistant Staphylococcus aureus (MRSA) in the UK

This review outlines the oral treatment options available for treating skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus (MRSA) in the community and discusses the evidence supporting their use.